Cannabis Johns Hopkins study shows synthetic THC helps treat Alzheimer’s It found that patients' agitation was reduced by 30% on average after taking a tablet with the artificial cannabinoid Rowan DunneOctober 4, 2024
Medical and Pharmaceutical Biogen ends 17-Year Aduhelm alzheimer’s drug study Aduhelm's troubled journey and the pursuit of new horizons Zartasha MushtaqFebruary 5, 2024